Last reviewed · How we verify
NCT04695678
Epidemiological Multicohort Study of Latent COVID-19 Infections
trial testing COVID-19 nasal/pharyngeal swab in COVID-19 in 1,462 participants. Completed in 30 December 2021.
30 July 2021
Quick facts
| Lead sponsor | Wissenschaftliches Institut Bethanien e.V |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,462 |
| Start date | 1 July 2020 |
| Primary completion | 30 July 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- COVID-19 nasal/pharyngeal swab
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
Wissenschaftliches Institut Bethanien e.V
Who can join
18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cross-sectional study to detect latent COVID-19 infections in residents and staff of old people's and nursing homes in the city of Solingen with a prospective follow-up of 6 months in a subgroup.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04695678
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Wissenschaftliches Institut Bethanien e.V trials
Trials by the same sponsor.
- NCT06861686 — A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores · recruiting
- NCT06179342 — Multiple Breath Washout as a Method for Diagnosing Lung Diseases · completed
- NCT04527497 — Clinical Course and Treatment of COVID-19 Inpatients in Hospital · completed
- NCT04521088 — Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic · completed
- NCT04093427 — Influence of an Inverse Pressure Ramp in Long-term Non-invasive Ventilation on Dyspnea in the Morning After Therapy · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04695678 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wissenschaftliches Institut Bethanien e.V
- Last refreshed: 27 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04695678.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing